Pharmacokinetics of eribulin mesilate in combination with capecitabine in patients with advanced/metastatic cancer: Results from a phase IB dose-escalation study

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Twelves CJ, Nasim M, Anthoney A, Cresti N, Savulsky C, Johnston C, Reyderman L, Wanders J, Plummer R, Evans TRJ

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 37th Congress of the European Society for Medical Oncology (ESMO)

Year of Conference: 2012

Pages: 129-129

ISSN: 0923-7534

Publisher: Oxford University Press

URL: http://dx.doi.org/10.1093/annonc/mds393

DOI: 10.1093/annonc/mds393

Library holdings: Search Newcastle University Library for this item

Series Title: Annals of Oncology

ISBN: 15698041

ePrints